Becerra Rojas, F., Benites Chacaltana, C., Aiello, E., Zingoni, C., Bergman, G., Drost, P., & Sanabria Montañez, C. (2024). Cost-effectiveness of abatacept compared to other biological agents for the treatment of moderately to severely active rheumatoid arthritis in patients who failed with methotrexate in Peruvian Social Security during 2010.
Citación estilo ChicagoBecerra Rojas, Felipe, César Benites Chacaltana, Eleonora Aiello, Carolina Zingoni, Gert Bergman, Pieter Drost, y César Sanabria Montañez. Cost-effectiveness of Abatacept Compared to Other Biological Agents for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Patients Who Failed With Methotrexate in Peruvian Social Security During 2010. 2024.
Cita MLABecerra Rojas, Felipe, et al. Cost-effectiveness of Abatacept Compared to Other Biological Agents for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Patients Who Failed With Methotrexate in Peruvian Social Security During 2010. 2024.